COSTA, ALFREDO ARTURO
 Distribuzione geografica
Continente #
NA - Nord America 16.854
AS - Asia 9.818
EU - Europa 8.902
SA - Sud America 1.426
Continente sconosciuto - Info sul continente non disponibili 487
AF - Africa 318
OC - Oceania 24
Totale 37.829
Nazione #
US - Stati Uniti d'America 16.407
CN - Cina 4.738
SG - Singapore 2.327
IT - Italia 2.262
IE - Irlanda 1.525
BR - Brasile 1.051
UA - Ucraina 949
HK - Hong Kong 905
DE - Germania 875
VN - Vietnam 852
FI - Finlandia 810
RU - Federazione Russa 747
FR - Francia 503
SE - Svezia 419
GB - Regno Unito 366
IN - India 221
CA - Canada 215
BD - Bangladesh 132
ZA - Sudafrica 131
AR - Argentina 120
IQ - Iraq 100
NL - Olanda 88
JP - Giappone 86
MX - Messico 84
PL - Polonia 61
ES - Italia 54
ID - Indonesia 53
TR - Turchia 53
CO - Colombia 51
EC - Ecuador 50
VE - Venezuela 49
PK - Pakistan 47
MA - Marocco 39
SA - Arabia Saudita 38
AT - Austria 34
UZ - Uzbekistan 33
CL - Cile 32
CZ - Repubblica Ceca 31
BE - Belgio 28
MY - Malesia 25
PE - Perù 25
PH - Filippine 24
EG - Egitto 23
TN - Tunisia 23
CH - Svizzera 22
PY - Paraguay 22
JO - Giordania 21
LT - Lituania 21
AU - Australia 20
KE - Kenya 20
NP - Nepal 20
CR - Costa Rica 17
GT - Guatemala 16
JM - Giamaica 16
AZ - Azerbaigian 15
AE - Emirati Arabi Uniti 14
AL - Albania 14
DZ - Algeria 14
SV - El Salvador 14
UY - Uruguay 14
ET - Etiopia 13
HN - Honduras 13
NI - Nicaragua 13
RO - Romania 13
TH - Thailandia 13
PT - Portogallo 12
TT - Trinidad e Tobago 12
KR - Corea 11
BO - Bolivia 10
DO - Repubblica Dominicana 10
IL - Israele 10
MZ - Mozambico 10
DK - Danimarca 9
MU - Mauritius 9
PR - Porto Rico 9
TW - Taiwan 9
KG - Kirghizistan 8
RS - Serbia 8
EU - Europa 7
GR - Grecia 7
BG - Bulgaria 6
HU - Ungheria 6
NG - Nigeria 6
PA - Panama 6
PS - Palestinian Territory 6
AM - Armenia 5
CW - ???statistics.table.value.countryCode.CW??? 5
EE - Estonia 5
GE - Georgia 5
KZ - Kazakistan 5
MD - Moldavia 5
OM - Oman 5
QA - Qatar 5
AO - Angola 4
BB - Barbados 4
BH - Bahrain 4
IR - Iran 4
KH - Cambogia 4
KW - Kuwait 4
MK - Macedonia 4
Totale 37.270
Città #
Chandler 1.557
Dublin 1.522
San Jose 1.516
Ashburn 1.337
Jacksonville 1.271
Dallas 1.250
Singapore 1.189
Nanjing 1.017
Hong Kong 886
Council Bluffs 832
Beijing 634
Boardman 527
Nanchang 412
Los Angeles 357
Princeton 319
Lauterbourg 317
Changsha 299
Ho Chi Minh City 298
Lawrence 297
Shenyang 297
Hebei 292
Wilmington 285
Milan 258
Jiaxing 239
New York 234
Helsinki 211
Hanoi 210
Hangzhou 202
Munich 183
Tianjin 183
Medford 179
Santa Clara 169
Buffalo 156
Shanghai 141
Rome 136
Redondo Beach 133
Moscow 131
Johannesburg 110
Pavia 109
Ann Arbor 107
São Paulo 106
Atlanta 94
Orem 86
Tokyo 83
Woodbridge 83
Turku 75
Chicago 71
Houston 65
Phoenix 63
Toronto 58
Montreal 57
San Francisco 56
Naples 55
Norwalk 55
Frankfurt am Main 54
Brooklyn 50
Fairfield 49
Da Nang 48
Columbus 47
London 47
Guangzhou 45
Seattle 45
Warsaw 44
Denver 39
Palermo 39
Turin 39
Pune 38
Rio de Janeiro 37
Baghdad 36
Florence 36
Haiphong 36
The Dalles 36
Verona 34
Chennai 33
Mexico City 32
Bologna 31
Belo Horizonte 30
Falkenstein 30
Boston 29
Stockholm 29
Tashkent 29
Genoa 28
Manchester 28
Piscataway 28
Brussels 25
Kunming 25
Redwood City 24
Zhengzhou 24
Mumbai 23
Newark 23
Brno 22
Washington 21
Brasília 20
Düsseldorf 20
Nuremberg 20
Amman 19
Des Moines 19
Paris 19
Amsterdam 18
Biên Hòa 18
Totale 22.275
Nome #
Effect of Diazepam on 24-Hour Blood Pressure and Heart Rate in Healthy Young Volunteers 988
Adams e Victor - Principi di Neurologia / Adams, Victor - Principles of Neurology 831
Stress e sindromi da ipereccitabilita' neuronale. 683
Effects of oral administration of alprazolam and lorazepam as hypnotics on cardiovascular parameters in hypertensive patients. 336
Effect of Evening Bromazepam Administration on Blood Pressure and Heart Rate in Mild Hypertensive Patients 286
A data-driven cluster analysis to explore cognitive reserve and modifiable risk factors in early phases of cognitive decline 266
Nitric oxide pathway and response to nitroglycerin in cluster headache patients: plasma nitrite and citrulline levels 265
Advancing dementia care: a review of Italy’s public health response within the WHO Global Action Plan and European strategies 234
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 211
Adams, Victor, Ropper - Principi di Neurologia / Adams, Victor, Ropper's Principles of Neurology 193
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 189
Arterial hypertension in the chronic evolution of migraine: bystander or risk factor? An overview 182
3D kinematic analysis and clinical evaluation of neck movements in patients with whiplash injury 180
Harrison - Principi di Medicina Interna / Harrison's Principles of Internal Medicine 174
Nitric oxide-induced neuronal activation in the central nervous system as an animal model of migraine:mechanisms and mediators. 164
A case of Wernicke’s enkephalopathy associated with disulfiram intoxication. 157
Adult-onset type II glycogenosis (GSDII): Clinical spectrum and enzyme replacement therapy (ERT) 152
Changes in nutritional status and body composition during enzyme replacementtherapy in adult-onset type II glycogenosis. 151
A machine learning approach for the differential diagnosis of Alzheimer and vascular dementia fed by MRI selected features. 151
Essential Amino Acid Supplementation May Attenuate Systemic Inflammation and Improve Hypoalbuminemia in Subacute Hemiplegic Stroke Patients 151
Cognitive impairment in depression: recent advances and novel treatments. 150
Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant. 149
Specific patterns of white matter alterations help distinguishing Alzheimer's and vascular dementia 143
PSEN1 Compound Heterozygous Mutations Associated with Cerebral Amyloid Angiopathy and Cognitive Decline Phenotype 142
Bisdemethoxycurcumin (BDC)-Loaded H-Ferritin-Nanocages Mediate the Regulation of Inflammation in Alzheimer’s Disease Patients 141
COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature 139
A clinical-epidemiological approach to the nosography of the neuronal hyperexcitability syndrome. 138
Correlation of frontal atrophy and CSF tau levels with neuropsychiatric symptoms in patients with cognitive impairment: a memory clinic experience 137
Cognitive impairment and central motor conduction time in chronic alcoholics. 136
Clinical Perception and Treatment Options for Behavioral and Psychological Symptoms of Dementia (BPSD) in Italy 135
Diazepam as an oral hypnotic increases nocturnal blood pressure in the elderly. 131
Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement 130
Pituitary-adrenal function and cognitive performance in demented patients on acetyl-L-carnitine treatment 129
Mini Nutritional Assessment May Identify a Dual Pattern of Perturbed Plasma Amino Acids in Patients with Alzheimer's Disease: A Window to Metabolic and Physical Rehabilitation? 129
Vascular lesions and brain atrophy in Alzheimer's, vascular and mixed dementia: an optimized 3T MRI protocol reveals distinctive radiological profiles 128
A novel ATP1A2 mutation in a family with FHM type II 127
Capacity to consent to research in older adults with normal cognitive functioning, mild and major neurocognitive disorder: an Italian study 126
Dementia and Cerebrovascular Disease. 126
Recombinant alpha-glucosidase in adult-onset type II glycogenosis: The experience with the first Italian patient, from expanded access programmes to marketing authorization 125
Nitroglycerin-induced cluster headache: successful treatment with intranasal lidocain and cocaine 125
Early cortical and late striatal diffusion restriction on 3T MRI in long-lived sporadic Creutzfeldt-Jakob disease case. 125
Enzyme replacement therapy in adult-onset type II glycogenosis 125
A Call for Drug Therapies for the Treatment of Social Behavior Disorders in Dementia: Systematic Review of Evidence and State of the Art 124
Adult-onset type II glycogenosis (GSDII): Clinical spectrum and enzyme replacement therapy (ERT) 124
Recent advances in migraine therapy. 124
Benzodiazepins and cardiovascular risk: recent acquisitions and revision of literature. 124
Aging and dementia: markers of the hypothalamus-pituitary-adrenal axis and sympathetic activities in biological fluids 123
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patientswith Alzheimer's disease and vascular dementia. 123
Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. 122
Early-onset ptosis in type II glycogenosis 122
Le Demenze - Manuale di diagnosi e trattamento 122
Leukocite derived microvescicles as disease progression biomarkers in slow progressing amyotrophic lateral sclerosis. 122
Aging female brain: is there a change of adaptive stress? 122
Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients 121
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 121
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 121
Aspetti clinici e patogenetici della comorbidita’ emicranica. 120
Cefalea a grappolo e disturbi dell’affettività: la melatonina come marker di un comune terreno biologico. 120
7th International Headache Seminar. 120
The angiotensin-converting enzyme insertion/deletion polymorphysm modifies the clinical outcome in patients with Pompe disease. 119
Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers. 119
Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer's Disease 119
Estradiol reduces cytochrome c translocation and minimizes hippocampal damage caused by transient global ischemia in rat. 119
The neuropharmacology of cluster headache and trigeminal autonomic cephalalgias 118
Le demenze da cause metabolico-nutrizionali, da disfunzioni endocrine e da agenti tossici: una rivisitazione. 118
Activation of the central nervous system with nitric oxide donors in the animal: mechanisms and mediators 118
Headache and commuting: preliminary data in a group of workers. 118
Copper imbalance in alzheimer’s disease: Meta-analysis of serum, plasma, and brain specimens, and replication study evaluating atp7b gene variants 118
Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling 118
Acute amnestic syndrome in fornix lesions: a systematic review of reported cases with a focus on differential diagnosis 117
Acetyl-L-carnitine, adrenocortical hyperactivity and pathological aging brain 117
Assessing the relative incidence of mitochondrial DNA A3243G in migraine without aura with maternal inheritance 116
Immune-mediated neuropathies in myeloma patients treated with bortezomib. 116
The impact of COVID-19 quarantine on patients with dementia and family caregivers: a nation-wide survey. 116
Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder 116
BPSDiary study protocol: a multi-center randomized controlled trial to compare the efficacy of a BPSD diary vs. standard care in reducing caregiver's burden 115
Aging female brain: is there a change of adaptive stress? 115
Different miRNA profiles in plasma derived small and large extracellular vesicles of neurodegenerative disease patients. 115
Investigating neuropathological correlates of hyperactive and psychotic symptoms in dementia: a systematic review 114
Il Naproxene sodico nella profilassi dell'emicrania mestruale 114
Frontal and cerebellar atrophy supports FTSD-ALS clinical continuum 114
Emicrania emiplegica familiare: dalla genetica alla clinica. 113
Adrenocortical hyperactivity and Alzheimer's disease: effects of acetyl-L-carnitine treatment. 113
Technostress and primary headache: psychosocial risk. 112
Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients 112
Polypharmacy, drug-drug interactions, anticholinergic burden and cognitive outcomes: a snapshot from a community-dwelling sample of older men and women in northern Italy 111
Chronic daily headache: old problems, new vistas 111
Coenzyme Q-10 and migraine: a lovable relationship. The experience of a tertiary headache center. 111
The renin-angiotensin system: phylogenetic aspects. 111
Outcomes of a computer-based cognitive training (CoRe) in early phases of cognitive decline: a data-driven cluster analysis 110
Clinical and MRI logitudinal study in two case-reports of long-lasting sCJD patients 110
Equating conversion norms for the Mini-Mental State Examination and Montreal Cognitive Assessment in healthy subjects and patients with neurodegenerative disorders 108
Spettro clinico dell’emicrania: ai confini di un iceberg. 108
The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone relase from acute rat hypothalamic explants. 108
Medicina complementare e cefalee primarie 107
The roles of nitric oxide and carbon monoxide in neuroendocrinology 107
Enzyme replacement therapy in severe adult-onset glycogen storage disease type II 107
Advancing Italian biomedical information extraction with transformers-based models: Methodological insights and multicenter practical application 106
Tutti i farmaci per il trattamento del’emicrania 106
I disturbi cognitivi nel paziente depresso: recenti acquisizioni e ruolo della vortioxetina 106
Totale 15.601
Categoria #
all - tutte 154.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 154.131


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.179 0 0 0 27 15 67 20 71 89 28 219 643
2022/20234.622 455 320 38 393 453 495 15 302 1.886 45 139 81
2023/20241.968 206 297 66 151 159 448 84 100 30 102 133 192
2024/20254.711 118 408 145 171 122 201 286 346 1.039 248 464 1.163
2025/202611.840 805 982 1.444 1.269 1.340 495 2.153 504 987 890 622 349
2026/20274.804 872 1.376 1.140 1.416 0 0 0 0 0 0 0 0
Totale 37.829